Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SELLAS Life Sciences Q2 EPS $(0.30) Up From $(0.66) YoY

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(0.30) per share. This is a 54.55 percent increase over losses of $(0.66) per share from the same period last year.

byMichael Horton

August 12, 2021

1 minute read

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(0.30) per share. This is a 54.55 percent increase over losses of $(0.66) per share from the same period last year.

Verizon With Stable & Growing Dividend Likely To Hold In Far Better Than Peer TMTs, Analyst Says

By Anusuya Lahiri

Today, 6:17 AM

Raymond James analyst Frank G. Louthan maintained an Outperform rating on Verizon Communications Inc (NYSE:VZ) and cut the price target to $54…

UPDATE: Assertio Therapeutics Q3 Adj. EPS $0.22 Beats $0.07 Estimate

By Benzinga Newsdesk

Today, 6:17 AM

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share

ASRT